Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020

Women s Health Issues(2023)10.1016/j.whi.2023.10.004Source: DataRank Database

Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020 is a research paper published in Women s Health Issues (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.47)OA: greenTopics (39)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Aniket Kulkarni ORCID,Antoinette T. Nguyen ORCID,Lauren B. Zapata ORCID,Katherine Kortsmit ORCID,Ruben A Smith ORCID

Live enrichment

PubMed:38065719 PMC:PMC11283820 OpenAlex:https://openalex.org/W4389455657

Intramural CDC HHS

Grant: CC999999

Centers for Disease Control and Prevention

FWCI

0.47

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11283820/pdf/nihms-1977073.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1049386723001858?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1049386723001858?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11283820

Fields of Study

Reproductive Health and ContraceptionCOVID-19 Impact on ReproductionGlobal Maternal and Child HealthFemaleUnited StatesHumansContraceptive Agents, FemalePandemicsCOVID-19ContraceptionInsurance

MeSH Terms

COVID-19ContraceptionContraceptive Agents, FemaleFemaleHumansInsuranceUnited StatesPandemics

Keywords

MedicinePillPandemicTelehealthFamily medicineDemographyPopulationPsychological interventionPharmacyLong-acting reversible contraceptionCoronavirus disease 2019 (COVID-19)Family planningTelemedicineHealth careEnvironmental healthPolitical scienceResearch methodologyNursingLawInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being

Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020

FAIR Checklist

Authors (7)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)